title: [Blind prophylactic antibiotic administration in premature rupture of fetal membranes].
abstract: In a retrospective study based on patients treated at the Department of Gynecology and Obstetrics of the University of Cologne during 1984-1993, we tested whether antepartal prophylactic application of antibiotics in patients with premature rupture of membranes (PROM) decreases the frequency of maternal or fetal infections. With raising intervals between PROM and birth exceeding 24 hours, the frequency of maternal/fetal infections raised in the total study population (n = 940). The maternal infection rate increased from 4% to 11% and the frequency of fetal sepsis from 4% to 19% with a PROM to birth interval exceeding 24 hours. In the group of patients with prophylactic application of antibiotics the frequency of maternal or fetal infections was not lower than in the group without antibiotics. This holds true for the total study population as well as for subgroups with different gestational ages. In the total study population 12% of antibiotics-treated patients and 22% of their newborns had peripartal infections, whereas in the untreated population 3% of the mothers and 4% of the newborns showed signs of infection. The prophylactic application of antibiotics raises significantly the latency period in combination with or without tocolysis in PROM during 25. and 37. week of gestation.
authors.affiliation: Universitäts-Frauenklinik, J. W. Goethe Universität Frankfurt/M.
authors.forename: A
authors.initials: A
authors.lastname: Ahr
authors.forename: A
authors.initials: A
authors.lastname: Scharl
authors.forename: U J
authors.initials: UJ
authors.lastname: Göhring
authors.forename: W
authors.initials: W
authors.lastname: Neuhaus
authors.forename: M
authors.initials: M
authors.lastname: Kaufmann
mesh_terms: D019072:Antibiotic Prophylaxis; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy*; D002821:Chorioamnionitis / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000175:diagnosis / Q000188:drug therapy*; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D012189:Retrospective Studies; D015145:Tocolysis; D016896:Treatment Outcome